Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1560 studies found for:    Open Studies | "Kidney Diseases"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Kidney Diseases"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease
Conditions: Chronic Kidney Disease;   Autosomal Dominant Polycystic Kidney Disease
Interventions: Drug: Tolvaptan (OPC-41061);   Drug: Placebo
2 Not yet recruiting New Quantitive MRI Parameters in Assessing Kidneys of Autosomal Dominant Polycystic Kidney Disease
Conditions: Autosomal Dominant Polycystic Kidney Disease;   Kidney Disease
Intervention:
3 Recruiting Pyridorin in Diabetic Nephropathy
Conditions: Diabetic Nephropathy;   Diabetic Kidney Disease
Interventions: Drug: Pyridorin;   Drug: Placebo
4 Recruiting Family Investigation of Nephropathy and Diabetes (F.I.N.D.)
Conditions: Diabetic Nephropathy;   Diabetes Mellitus;   Diabetic Kidney Disease;   Albuminuria
Intervention:
5 Unknown  Mycophenolate Mofetil, Carnitine and PDE5 Inhibitor, Three Potential Treatments for Resistant Proteinuria Slowing Diabetic Nephropathy Deterioration
Conditions: Diabetic Nephropathy;   Chronic Kidney Disease
Intervention: Drug: Mycophenolate Mofetil (MMF) ,phosphodiesterase 5 inhibitors , CARNITINE
6 Recruiting Repository Study of Autosomal Dominant Polycystic Kidney Disease
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention:
7 Recruiting Mesenchymal Stem Cells Transplantation in Patients With Chronic Renal Failure Due to Polycystic Kidney Disease
Conditions: Chronic Renal Failure;   Polycystic Kidney Disease
Intervention: Biological: Intravenous injection autologous mesenchymal stem cells
8 Unknown  Risk Stratification in End Stage Renal Disease (ESRD)
Conditions: End Stage Renal Disease;   Chronic Kidney Disease;   Cardiovascular Event;   Sudden Cardiac Death
Intervention:
9 Not yet recruiting Lanreotide In Polycystic Kidney Disease Study
Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD
Interventions: Drug: Lanreotide;   Drug: saline
10 Recruiting Pilot Study of Velcade® in IgA Nephropathy
Conditions: Chronic Kidney Disease;   IgA Nephropathy
Intervention: Drug: Bortezomib (Velcade®)
11 Recruiting Improving Evidence-Based Primary Care for Chronic Kidney Disease
Conditions: Chronic Kidney Disease;   Chronic Kidney Insufficiency;   Chronic Renal Diseases;   Chronic Renal Insufficiency;   Kidney Insufficiency, Chronic
Interventions: Other: Facilitated Clinical Decision Support;   Other: Clinical Decision Support Only
12 Recruiting Primary Cardiovascular Risk Prevention With Aspirin in Chronic Kidney Disease Patients
Conditions: Chronic Kidney Disease Stage 4;   Chronic Kidney Disease Stage 3
Intervention: Drug: Aspirin
13 Not yet recruiting The Efficacy of Everolimus in Reducing Total Native Kidney Volume in Polycystic Kidney Disease Transplanted Recipients
Condition: Autosomal Dominant Polycystic Kidney Disease
Interventions: Drug: Everolimus;   Drug: Calcineurin inhibitors maintenance
14 Recruiting Effects of PINTA 745 in End Stage Renal Disease (ESRD) Patients Who Require Hemodialysis and Have Protein Energy Wasting
Conditions: End Stage Renal Disease;   Kidney Disease;   Protein Energy Wasting
Interventions: Drug: PINTA 745;   Drug: Placebo
15 Not yet recruiting Open-label Trial to Evaluate the Long Term Safety of Titrated Immediate-release Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention: Drug: Tolvaptan (OPC-41061)
16 Recruiting N-Acetyl Cystein and Contrast Nephropathy
Conditions: Chronic Kidney Disease Stage 2;   Radiographic Contrast Agent Nephropathy
Interventions: Drug: Oral N-Acetyl Cystein;   Drug: IV N-Acetyl Cystein;   Drug: Placebo group
17 Recruiting Polycystic Kidney Disease Data Repository
Condition: Polycystic Kidney Disease
Intervention:
18 Recruiting Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)
Conditions: Kidney Diseases;   Kidney Failure, Chronic;   Diabetic Nephropathy;   Lupus Nephritis;   Glomerulonephritis, IGA
Intervention:
19 Recruiting Uncontrolled, Open Label, Pilot and Feasibility Study of Niacinamide in Polycystic Kidney Disease
Condition: Polycystic Kidney Disease
Intervention: Dietary Supplement: Niacinamide
20 Unknown  Impact of Vitamin D on Diabetic Kidney Disease in African Americans
Condition: Diabetic Kidney Disease
Intervention: Drug: Vitamin D3

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years